Skip to main content

Advertisement

Open Peer Review Reports for: FAM168A participates in the development of chronic myeloid leukemia via BCR-ABL1/AKT1/NFκB pathway

Back to article

Pre-publication versions of this article are available by contacting info@biomedcentral.com.

Original Submission
30 Oct 2018 Submitted Original manuscript
2 Jan 2019 Reviewed Reviewer Report - Xiangmin Tong
13 Feb 2019 Reviewed Reviewer Report - Reviewer 2
23 Apr 2019 Author responded Author comments - Xiaorong Liu
Resubmission - Version 2
23 Apr 2019 Submitted Manuscript version 2
8 May 2019 Reviewed Reviewer Report - Reviewer 2
14 Jun 2019 Reviewed Reviewer Report - Reviewer 3
25 Jun 2019 Author responded Author comments - Xiaorong Liu
Resubmission - Version 3
25 Jun 2019 Submitted Manuscript version 3
27 Jun 2019 Author responded Author comments - Xiaorong Liu
Resubmission - Version 4
27 Jun 2019 Submitted Manuscript version 4
Publishing
2 Jul 2019 Editorially accepted
10 Jul 2019 Article published 10.1186/s12885-019-5898-4

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.

You can find further information about the peer review system here.

Advertisement